Working…
ClinicalTrials.gov

Key Record Dates

ClinicalTrials.gov Identifier: NCT03289962
Brief Title: A Study of Autogene Cevumeran (RO7198457) as a Single Agent and in Combination With Atezolizumab in Participants With Locally Advanced or Metastatic Tumors

First Submitted : September 19, 2017
First Submitted that Met QC Criteria : September 19, 2017
First Posted : September 21, 2017

Last Update Submitted that Met QC Criteria : July 6, 2021
Last Update Posted : July 8, 2021